|
Volumn 85, Issue 412, 1996, Pages 49-51
|
Serological screening for coeliac disease: Methodological standards and quality control
a a a |
Author keywords
Coeliac disease; serological screening
|
Indexed keywords
CELIAC DISEASE;
CLINICAL PROTOCOL;
CONFERENCE PAPER;
ENZYME LINKED IMMUNOSORBENT ASSAY;
HUMAN;
HUMAN CELL;
METHODOLOGY;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
QUALITY CONTROL;
SCREENING TEST;
SEROLOGY;
STANDARD;
ARTICLE;
BLOOD;
CASE CONTROL STUDY;
CHILD;
CLINICAL TRIAL;
EUROPE;
FLUORESCENT ANTIBODY TECHNIQUE;
HEALTH CARE ORGANIZATION;
IMMUNOLOGY;
MASS SCREENING;
MULTICENTER STUDY;
REPRODUCIBILITY;
SENSITIVITY AND SPECIFICITY;
GLIADIN;
IMMUNOGLOBULIN A;
CASE-CONTROL STUDIES;
CELIAC DISEASE;
CHILD;
CLINICAL PROTOCOLS;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
EUROPE;
FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT;
GLIADIN;
HUMANS;
IMMUNOGLOBULIN A;
MASS SCREENING;
QUALITY CONTROL;
REFERENCE STANDARDS;
REPRODUCIBILITY OF RESULTS;
SENSITIVITY AND SPECIFICITY;
SEROLOGIC TESTS;
SOCIETIES, SCIENTIFIC;
|
EID: 0029952691
PISSN: 08035326
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (36)
|
References (5)
|